An attempt to protect the ozone layer has effectively removed the only over-the-counter asthma inhaler from the market, forcing some asthma sufferers to find room in their budgets for visits ...

Prescription rescue inhalers deliver a class of drugs known as short-acting beta 2-agonists (SABAs). The OTC inhaler Primatene Mist (epinephrine inhalation aerosol) is also a short-acting ...

Primatene Mist inhalers (epinephrine inhalation aerosol) provide temporary relief from mild, intermittent asthma symptoms. The Primatene Mist inhaler is the only over-the-counter (OTC) asthma inhaler ...

Currently, the only FDA-approved OTC inhaler available to manage asthma symptoms is Primatene Mist (Amphastar Pharmaceuticals), an inhaled epinephrine product that was approved in 2018.

Primary Source Annals of ATS Source Reference: Sadreameli SC, et al. "The surprising reintroduction of Primatene Mist in the United States" Annals ATS 2019; DOI: 10.1513/AnnalsATS.201902-164HP.

Primatene MIST (epinephrine inhalation aerosol bronchodilator suspension; Amphastar) is now available over-the-counter (OTC) for the temporary relief of mild symptoms of intermittent asthma (eg ...

(RTTNews) - After 7 years of absence, asthma inhaler Primatene Mist, developed by Amphastar Pharmaceuticals, is reentering the market with renewed features. The over-the-counter epinephrine ...

Use this model would indicate a gross revenue stream of $75,000,000.00 for a user purchasing one Primatene Mist product.

A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It's ...